The therapeutic effects of blocking the PD-1 pathway via anti-PD-L1 antibody treatment is further exemplified during HIV infections, wherein antibody treatment enhanced HIV-specific CTL proliferation and cytokine production [23]. The gene discussed is CD274; the disease is HIV infectious disease.